The most common side effects of INVEGA HAFYERA® include: injection site reactions, weight gain, headache, upper respiratory ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2, ...

Analyst Jonathan Chang from Leerink Partners reiterated a Buy rating on Zai Lab (ZLAB – Research Report) and keeping the price target at ...

Health Union, the leading digital health company building online communities that empower people to live better with health challenges, has launched seven new communities over the past year, expanding ...

Schizophrenic drug user, Gregor Bauld, who stabbed his mother to death outside their £1m home after becoming convinced she ...

Medically reviewed by Kathleen Daly, MD Schizoid personality disorder (ScPD) causes traits like having few social ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2024, along with recent product highlights and corporate ...

Chronic inflammation has been shown to negatively affect the whole body, from cognition to joint health. Despite these ...

Gain insight on Rigel Pharmaceuticals, AbbVie and more in the latest Market Talks covering the Health Care sector.

Mental illnesses are on the rise in Pakistan, pointing to a crisis that has to be addressed on a larger scale Concern over ...

Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...